Home › Agent Hub › Agent Tools › Part D coverage by drug › Pitavastatin
Agent Tools
Pitavastatin is the generic ingredient; brand versions: Livalo. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,169 of 5,492 Medicare Part D and Medicare Advantage drug plans (75.9%) list Pitavastatin on their formulary, across 140 of 286 formularies. The most common placement is tier 3 (1,874 plans, 45% of those covering it). 0 of the covering plans require prior authorization (0%), 835 step therapy and 3,897 a quantity limit.
1,909 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 1,782 of them $0; 2,260 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 3,507 of 5,496 plans covered it (63.8%); 2027: 4,169 of 5,492 (75.9%).
Of 4,367 plans offered in both years, 541 added it to the formulary and 42 dropped it.
Among plans covering it both years, 16 moved it to a higher tier and 253 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 1,756 |
| Tier 2 | 318 |
| Tier 3 | 1,874 |
| Tier 4 | 176 |
| Tier 6 | 45 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 149 of 323 | 46.1% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,513 of 3,200 | 78.5% | 0% |
| Special needs plans (SNP) | 1,507 of 1,969 | 76.5% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 744 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 1 | 0 |
| Aetna Medicare | 611 of 631 | Tier 1 | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 226 of 226 | Tier 1 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 6 of 36 | Tier 1 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 27 of 27 | Tier 6 | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 99 of 114 | 86.8% |
| Alaska | 4 of 9 | 44.4% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 111 of 147 | 75.5% |
| Arkansas | 70 of 85 | 82.4% |
| California | 156 of 397 | 39.3% |
| Colorado | 83 of 106 | 78.3% |
| Connecticut | 42 of 54 | 77.8% |
| Delaware | 36 of 43 | 83.7% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 424 of 545 | 77.8% |
| Georgia | 127 of 149 | 85.2% |
| Guam | 1 of 1 | 100% |
| Hawaii | 34 of 50 | 68% |
| Idaho | 28 of 45 | 62.2% |
| Illinois | 117 of 132 | 88.6% |
| Indiana | 101 of 138 | 73.2% |
| Iowa | 54 of 64 | 84.4% |
| Kansas | 69 of 84 | 82.1% |
| Kentucky | 102 of 121 | 84.3% |
| Louisiana | 116 of 125 | 92.8% |
| Maine | 41 of 52 | 78.8% |
| Maryland | 21 of 49 | 42.9% |
| Massachusetts | 45 of 89 | 50.6% |
| Michigan | 115 of 182 | 63.2% |
| Minnesota | 42 of 63 | 66.7% |
| Mississippi | 88 of 104 | 84.6% |
| Missouri | 156 of 170 | 91.8% |
| Montana | 20 of 27 | 74.1% |
| Nebraska | 42 of 51 | 82.4% |
| Nevada | 74 of 100 | 74% |
| New Hampshire | 21 of 25 | 84% |
| New Jersey | 59 of 73 | 80.8% |
| New Mexico | 57 of 68 | 83.8% |
| New York | 173 of 215 | 80.5% |
| North Carolina | 153 of 176 | 86.9% |
| North Dakota | 21 of 26 | 80.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 139 of 171 | 81.3% |
| Oklahoma | 65 of 81 | 80.2% |
| Oregon | 66 of 92 | 71.7% |
| Pennsylvania | 261 of 323 | 80.8% |
| Puerto Rico | 4 of 64 | 6.3% |
| Rhode Island | 16 of 29 | 55.2% |
| South Carolina | 82 of 89 | 92.1% |
| South Dakota | 25 of 30 | 83.3% |
| Tennessee | 131 of 156 | 84% |
| Texas | 333 of 407 | 81.8% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 46 of 53 | 86.8% |
| Vermont | 8 of 14 | 57.1% |
| Virginia | 113 of 144 | 78.5% |
| Washington | 81 of 114 | 71.1% |
| West Virginia | 52 of 69 | 75.4% |
| Wisconsin | 73 of 96 | 76% |
| Wyoming | 8 of 13 | 61.5% |
Medicare Part D paid for 362,817 30-day fills of Pitavastatin in 2024 for about 49,030 enrollees, at an average total cost of $102.15 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Pitavastatin and the rest of a client's list on every plan in their county.
Estimate Pitavastatin costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.